Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00450788 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Esophageal Cancer in Northeastern Iran

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 332 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. New version filed on ClinicalTrials.gov
  2. 49 versions Re-verified since Sep 19, 2024, no change to tracked fieldsv283-v331
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: -Esophageal cancer is the most common cancer in Iran s Golestan Province. Nutritional deficiencies, ethnicity and environmental exposures might contribute to the development of this disease. Objectives: -To better understand the cause of esophageal cancer in Golestan Province and to reduce its occurrence there. Eligibility: -Adults from the Gonbad, Aq-Qala and Kalaleh districts of eastern Golestan Province in Iran. Design: * The study is a collaboration between NIH, the Digestive Disease Research Center of Teheran University of Medical Sciences, and the International Agency for Research on Cancer. * Participants complete a lifestyle questionnaire and food frequency questionnaire. * Samples of participants blood, urine, hair and toenail clippings are obtained.
Trial Details
NCT Number NCT00450788
Lead Sponsor National Cancer Institute (NCI)
Conditions Esophageal Cancer, GI Disease
Enrollment 50,045 participants
Start Date
Updated on ClinicalTrials.gov